Bavarian Nordic A/S

Bavarian Nordic A/S BAVA

Dividend Summary



There have not been any declared dividends recently.

Latest Dividends
Summary Previous dividend Next dividend
Status
Type
Per share
Declaration date
Ex-div date
Pay date

Enter the number of Bavarian Nordic A/S shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
We have not made any dividend predictions for Bavarian Nordic A/S
Dividend Yield Today
0.0%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for Bavarian Nordic A/S
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
There are no Bavarian Nordic A/S dividends.
Year Amount Change
2006 0.0öre
2007 0.0öre
0%
2008 0.0öre
0%
2009 0.0öre
0%
2010 0.0öre
0%
2011 0.0öre
0%
2012 0.0öre
0%
2013 0.0öre
0%
2014 0.0öre
0%
2015 0.0öre
0%
2016 0.0öre
0%
2017 0.0öre
0%
2018 0.0öre
0%
2019 0.0öre
0%
2020 0.0öre
0%
2021 0.0öre
0%
2022 Sign Up Required

Bavarian Nordic A/S Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
0.0%
Optimized Yield
Sign Up Required
52 Week High
0.0% on 07 March 2022
52 Week Low
0.0% on 07 March 2022
Next Ex-Div-Date Countdown
Sign Up Required

About Bavarian Nordic A/S

Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of cancer and infectious diseases. The Company’s drug pipeline comprises two areas: Cancer Immunotherapy and Infectious Disease. The Cancer Immunotherapy pipeline is focused on: prostate cancer, including PROSTVAC and Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) PRO; breast cancer, providing CV-301 breast and MVA-BN HER2 vaccines; and colorectal cancer, offering CV-301 colon. The Infectious Disease pipeline produces vaccines for a range of illnesses, such as smallpox, anthrax, filoviruses, foot-and-mouth diseases and respiratory syncytial virus. The Company is a parent of Bavarian Nordic GmbH, BN Infectious Diseases A/S, and Bavarian Nordic Inc, among others.

Sector
Pharmaceuticals & Biotechnology
Country
Denmark
Share Price
kr.230.90 (yesterday's closing price)
Shares in Issue
71 million
Market Cap
kr.16.3bn
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
0
Market Indices
none
No articles found